Gerstein Fisher’s AbbVie ABBV Stock Holding History

Gerstein Fisher’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$3.02M	Buy	47,877 +1,116	+2%	+$72.2K	0.37%	49
2016 Q2	$2.9M	Buy	46,761 +2,267	+5%	+$138K	0.38%	48
2016 Q1	$2.54M	Buy	44,494 +884	+2%	+$49.3K	0.35%	55
2015 Q4	$2.58M	Buy	43,610 +657	+2%	+$37.8K	0.36%	47
2015 Q3	$2.34M	Sell	42,953 -66	-0.2%	-$4.3K	0.35%	49
2015 Q2	$2.89M	Buy	43,019 +1,122	+3%	+$73.2K	0.47%	36
2015 Q1	$2.45M	Sell	41,897 -52	-0.1%	-$3.14K	0.4%	45
2014 Q4	$2.76M	Sell	41,949 -78	-0.2%	-$4.92K	0.45%	42
2014 Q3	$2.43M	Buy	42,027 +5,667	+16%	+$315K	0.43%	39
2014 Q2	$2.05M	Sell	36,360 -261	-0.7%	-$13.7K	0.39%	47
2014 Q1	$1.88M	Sell	36,621 -38,295	-51%	-$1.94M	0.38%	48
2013 Q4	$16.1M	Buy	74,916 +39,825	+113%	+$1.96M	0.6%	44
2013 Q3	$1.57M	Sell	35,091 -207	-0.6%	-$9.18K	0.34%	53
2013 Q2	$1.46M	Buy	+35,298	New	+$1.54M	0.35%	44

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Gerstein Fisher's ABBV Position: Q3 2016 in Review

Gerstein Fisher increased its AbbVie (ABBV) stake by 2.4% in Q3 2016, buying an estimated $72.2K and bringing the position to 47,877 shares worth $3.02M. The position accounts for 0.37% of the portfolio, ranked #49.

Gerstein Fisher first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $16.1M in Q4 2013. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

Gerstein Fisher held 47,877 shares of AbbVie worth $3.02M as of Q3 2016.
Gerstein Fisher bought 1,116 AbbVie shares in Q3 2016, an estimated $72.2K.
AbbVie made up 0.37% of Gerstein Fisher's portfolio in Q3 2016, its #49 holding.
Gerstein Fisher first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
Gerstein Fisher's AbbVie position peaked at $16.1M in Q4 2013.
1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.